Breast Imaging Technology Marketto Grow at 6.90% CAGR by 2030
Significantly rising prevalence for breast cancer, technological advancement, rising awareness of breast cancer are the major factors which are expected to drive the growth of Breast Imaging Technology industry during the forecast period of 2020-2030.
The Breast Imaging Technology Market is expected to witness a CAGR of around 6.90% from 2020-2030, as per a new report published by Next Move Strategy Consulting.
According to the report, rising in the prevalence of the breast cancer across the glove is the key factor driving the growth of the global breast imaging technologies market. Key industry participants in breast imaging technology market are coming up with initiatives to educate women about health and breast cancer awareness. This factor also significantly contributes in the growth of breast imaging technologies market. According the report published by UNICEF, percentage of women who are diagnosed with breast cancer is growing each year. This is due to breast cancer is the second most common types of cancer across the globe. It altogether is offering the scope for breast imaging technologies to help and cure breast cancer by encouraging its adoption rate, which in turn expected to further drive the growth for breast imaging technology market.
Based on product, the global breast imaging technology market share is segmented into ionizing breast imaging technologies and non ionizing breast imaging technologies. Ionizing breast imaging technologies accounted for the largest market shares in 2019and it is expected to maintain the lead in the coming years. Technological advancement in the ionizing breast imaging technology linked with the rising awareness about breast cancer resulted into early diagnosis thereby driving the growth of ionizing breast technology. Europe is the largest region wherein adoption rate of ionizing breast imaging technology is greater as compared to other region. This is due to growing number of regulatory approvals regarding advance number of breast imaging modalities, rise in the number of distribution collaboration mergers among key industry participants, and implementation of various awareness initiatives by several European companies. This is expected to drive Europe breast imaging technology market growth over the forecast period.
Ionizing breast imaging technology is further segmented into mammography, PET-CT, MBI, and PEM. Among all segment MBI is the largest due to fast, simple and easiness associated with it. This technology is highly sensitive and can be used patients with claustrophobic or allergic to gadolinium. One of the recently observed breast imaging technology market trend is rising use of MBI in allergic patients that serves the faster recovery.
The prominent players in the dental market are Dilon Technologies, Inc., FUJIFILM Holdings Corporation, Gamma Medica, Inc., General Electric Company, Hologic, Inc., Koning Corporation, Koninklijke Philips N.V., Siemens AG, Sonocin, Inc., and Toshiba corporation.
Key Insights from the Breast Imaging Technology Market Report:
- Europe is the global leader in the global Breast Imaging Technology market and is expected to maintain is lead during the forecast period
- The ionizing Breast Imaging Technology segment market share is expected to be more, due to associated benefits with it and rising awareness of breast cancer diagnosis
- Next Move Strategy Consulting has identified key players in breast imaging technology includes Dilon Technologies, Inc., FUJIFILM Holdings Corporation, Gamma Medica, Inc., General Electric Company, Hologic, Inc., Koning Corporation, Koninklijke Philips N.V., Siemens AG, Sonocin, Inc., and Toshiba corporation.
The report Breast Imaging Technology Market – Segmented by Product, and Geography